Given news of a severe shortage of the RSV immunization, Beyfortus, for infants, Tosa Pediatrics is prioritizing those at highest risk for RSV complications. We will begin by immediately immunizing those under 1 month of age and those under 2 months of age but born prematurely who are not receiving Synagis while supplies last. (Synagis prevents RSV in premature infants born at 28 weeks and under and in other special circumstances. If your child receives Synagis, there is no need to receive further RSV immunization.)
While we cannot guarantee we will have inventory, we will place your child on a prioritization list and email you when ready to immunize. Please do not call the office. Thank you for your understanding.
We ask that you review details including side effects and risks in advance. To learn more about Beyfortus, go to wwwbeyfortus.com or review information on the CDC at https://bit.ly/3tM9yWO